IL82516A0 - Extracts of nerium species,methods of preparation and use thereof - Google Patents

Extracts of nerium species,methods of preparation and use thereof

Info

Publication number
IL82516A0
IL82516A0 IL82516A IL8251687A IL82516A0 IL 82516 A0 IL82516 A0 IL 82516A0 IL 82516 A IL82516 A IL 82516A IL 8251687 A IL8251687 A IL 8251687A IL 82516 A0 IL82516 A0 IL 82516A0
Authority
IL
Israel
Prior art keywords
extracts
preparation
methods
nerium species
nerium
Prior art date
Application number
IL82516A
Other languages
English (en)
Original Assignee
Huseyin Ziya Ozel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huseyin Ziya Ozel filed Critical Huseyin Ziya Ozel
Publication of IL82516A0 publication Critical patent/IL82516A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL82516A 1986-05-13 1987-05-13 Extracts of nerium species,methods of preparation and use thereof IL82516A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86272086A 1986-05-13 1986-05-13
US4843587A 1987-05-11 1987-05-11

Publications (1)

Publication Number Publication Date
IL82516A0 true IL82516A0 (en) 1987-11-30

Family

ID=26726121

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82516A IL82516A0 (en) 1986-05-13 1987-05-13 Extracts of nerium species,methods of preparation and use thereof

Country Status (14)

Country Link
US (1) US5135745A (xx)
JP (1) JPS6322025A (xx)
KR (1) KR880013565A (xx)
CN (1) CN87104312A (xx)
AU (1) AU626516B2 (xx)
CA (1) CA1299100C (xx)
DK (1) DK239687A (xx)
FI (1) FI872106A (xx)
IL (1) IL82516A0 (xx)
IN (1) IN165073B (xx)
MC (1) MC1811A1 (xx)
NO (1) NO871978L (xx)
NZ (1) NZ220295A (xx)
PT (1) PT84857B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2354037A1 (en) * 1998-09-24 2000-03-30 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
AU2003227319B2 (en) * 1998-09-24 2007-07-26 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
KR100478146B1 (ko) * 2002-08-30 2005-03-22 재단법인 포항산업과학연구원 협죽도과 식물의 잎 추출물을 함유하는 고려잔디갈색퍼짐병 방제용 조성물 및 이를 이용하여 갈색퍼짐병을방제하는 방법
US20050112059A1 (en) * 2003-10-06 2005-05-26 Phoenix Biotechnology, Inc. Enhancement of radiotherapy by an exogenous cardiac glycoside
WO2005060951A2 (en) * 2003-12-19 2005-07-07 Bionaut Pharmaceuticals, Inc. Anti-neoplastic agents, combination therapies and related methods
JP2005289963A (ja) * 2004-03-12 2005-10-20 Hokubu Norin Koto Gakko Koenkai 抗腫瘍剤
US20060135468A1 (en) * 2004-09-02 2006-06-22 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using NA+/K+ ATPase inhibitors
US20060135442A1 (en) * 2004-09-02 2006-06-22 Bionaut Pharmaceuticals, Inc. Pancreatic cancer treatment using Na+/K+ ATPase inhibitors
US20070105790A1 (en) * 2004-09-02 2007-05-10 Bionaut Pharmaceuticals, Inc. Pancreatic cancer treatment using Na+/K+ ATPase inhibitors
US20060135441A1 (en) * 2004-09-02 2006-06-22 Bionaut Pharmaceuticals, Inc. Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors
US20080027010A1 (en) * 2004-09-02 2008-01-31 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using Na+/K+-ATPase inhibitors
US20060135443A1 (en) * 2004-10-18 2006-06-22 Bionaut Pharmaceuticals, Inc. Use of Na*/K*-ATPase inhibitors and antagonists thereof
US20060188536A1 (en) * 2005-02-15 2006-08-24 Phoenix Biotechnology Inc. Particles from processing of oleander leaves
JP2007008879A (ja) * 2005-06-30 2007-01-18 Yanbaru Green Health:Kk 抗腫瘍剤及びこれを含有する食品
US7402325B2 (en) * 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
EP1803461A1 (en) * 2005-12-27 2007-07-04 Heinz-Herbert Fiebig Therapeutic use of an extract from the leaves of Nerium oleander
WO2008078362A1 (ja) * 2006-12-22 2008-07-03 The Institute Of Biological Resources 抗腫瘍剤及びこれを含有する食品
US8486465B1 (en) * 2007-07-09 2013-07-16 Douglas CRAWFORD Therapeutic nerium oleander extract compositions and methods of using
CN101613414B (zh) * 2008-06-26 2011-09-07 中国科学院上海药物研究所 两种夹竹桃寡糖及其制备方法和用途
CA2739029C (en) * 2008-10-14 2018-07-10 Nerium Biotechnology, Inc. Process for extracting cardiac glycosides from plants and compositions comprising cardiac glycosides from nerium oleander
CN101416988B (zh) * 2008-12-07 2011-12-21 中国热带农业科学院热带生物技术研究所 采食长春花叶的夹竹桃天蛾幼虫粪便提取物在制备抗肿瘤药物中的用途
TR200900312A2 (tr) * 2009-01-15 2010-08-23 Levent Baş Ahmet Nerium oleander'in tip II diyabet, obezite, yüksek kolesterol ve trigliserid düzeyi ile seyreden hastalıklar ve kardiovasküler hastalıklarda kullanımı@
MX365635B (es) 2011-10-20 2019-06-10 Nerium Biotechnology Inc Combinacion terapeutica para el tratamiento de cancer.
US10702567B2 (en) 2016-09-14 2020-07-07 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
US10596186B2 (en) 2016-09-14 2020-03-24 Phoenix Biotechnology, Inc. Method and compositions for treating viral infections
EP3512524B1 (en) 2016-09-14 2021-04-07 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
US10729735B1 (en) 2016-09-14 2020-08-04 Phoenix Biotechnology, Inc. Method and compostitions for treating coronavirus infection
EP3681508A4 (en) 2017-09-14 2021-05-19 Phoenix Biotechnology, Inc. METHOD AND COMPOSITION FOR THE TREATMENT OF VIRAL INFECTION
EP4009981B1 (en) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
US11806359B2 (en) 2020-03-31 2023-11-07 Phoenix Biotechnology, Inc. Method and compositions for treating Coronavirus infection
ES2965161T3 (es) * 2020-03-31 2024-04-11 Phoenix Biotechnology Inc Método y composiciones para el tratamiento de infección por coronavirus
RU2020130238A (ru) 2020-03-31 2022-03-14 Феникс Байотекнолоджи, Инк. Способ и композиции для лечения коронавирусной инфекции
CA3091376C (en) * 2020-03-31 2023-09-19 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
US12097234B2 (en) 2020-05-24 2024-09-24 Phoenix Biotechnology, Inc. Extract containing oleandrin and method of production thereof

Also Published As

Publication number Publication date
CA1299100C (en) 1992-04-21
AU626516B2 (en) 1992-08-06
US5135745A (en) 1992-08-04
NO871978L (no) 1987-11-16
CN87104312A (zh) 1988-01-13
DK239687A (da) 1987-11-14
FI872106A0 (fi) 1987-05-12
DK239687D0 (da) 1987-05-12
PT84857A (en) 1987-06-01
AU7278587A (en) 1987-11-19
NO871978D0 (no) 1987-05-13
JPH0529332B2 (xx) 1993-04-30
PT84857B (pt) 1990-02-08
IN165073B (xx) 1989-08-12
NZ220295A (en) 1990-04-26
JPS6322025A (ja) 1988-01-29
FI872106A (fi) 1987-11-14
MC1811A1 (fr) 1988-03-18
KR880013565A (ko) 1988-12-21

Similar Documents

Publication Publication Date Title
IL82516A0 (en) Extracts of nerium species,methods of preparation and use thereof
EP0283505A4 (en) VACCINE AND PRODUCTION METHOD.
AU8015587A (en) 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols
ZA876068B (en) Method of preparation and use of solid,phytoactive compositions
EP0233615A3 (en) Aqueous preparation and method of preparation thereof
ZA879235B (en) Peridone derivatives,and their preparation and use
DE3662970D1 (en) Improved blood-purifying membrane and process for preparation thereof
DE3760806D1 (en) Monohalogenotrifluorooxetane and its preparation
GB2196002B (en) Preparation of polyfluoroaldehydes and polyfluoroacetals
EP0263309A3 (en) Bromofluoroethylhypofluorite and process for its preparation
EP0264060A3 (en) Anticoagulating substance and preparation process thereof
IL81920A0 (en) Vaccines and their preparation
AU8129987A (en) Pyrrolo-benzimidazoles, their preparation and use
GB2194235B (en) Dichlorotrifluoromethyltoluenes and preparation thereof
ZA872140B (en) Microlide compounds,their preparation and their use
AU8268887A (en) Aminoethylisoxazolidines, their preparation and use
EP0393339A3 (en) Preparation of pre-caseinates, and use
ZA877785B (en) Iminooxazolidines,process of preparation and method of use
GR862115B (en) Vaccine and preparation method thereof
BG42754A1 (en) Thiphosphatic derivative of ethylaminopropionamid, method for preparation and its use
ZA875294B (en) Novel tetrahydrobenzothiazole-quinolines,their preparation and use
AU629103C (en) Vaccine and method of preparation
IE872543L (en) Vaccine and method of preparation
ZA877087B (en) Vaccine and method of preparation
ZA871007B (en) Aminourethanes,preparation and use thereof